nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—MAOA—attention deficit hyperactivity disorder	0.336	0.399	CbGaD
Phentermine—SLC6A3—attention deficit hyperactivity disorder	0.29	0.344	CbGaD
Phentermine—SLC6A4—attention deficit hyperactivity disorder	0.217	0.257	CbGaD
Phentermine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.0103	0.194	CbGeAlD
Phentermine—MAOA—locus ceruleus—attention deficit hyperactivity disorder	0.00947	0.179	CbGeAlD
Phentermine—MAOB—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOA—attention deficit hyperactivity disorder	0.00897	0.0931	CbGpPWpGaD
Phentermine—MAOA—Enzymatic degradation of Dopamine by monoamine oxidase—COMT—attention deficit hyperactivity disorder	0.00567	0.0588	CbGpPWpGaD
Phentermine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00546	0.103	CbGeAlD
Phentermine—MAOB—Amine Oxidase reactions—MAOA—attention deficit hyperactivity disorder	0.00515	0.0535	CbGpPWpGaD
Phentermine—MAOA—Clearance of dopamine—SLC6A3—attention deficit hyperactivity disorder	0.00482	0.05	CbGpPWpGaD
Phentermine—MAOA—Clearance of dopamine—COMT—attention deficit hyperactivity disorder	0.0041	0.0425	CbGpPWpGaD
Phentermine—SLC6A3—Clearance of dopamine—COMT—attention deficit hyperactivity disorder	0.00381	0.0395	CbGpPWpGaD
Phentermine—SLC6A3—Clearance of dopamine—MAOA—attention deficit hyperactivity disorder	0.00378	0.0393	CbGpPWpGaD
Phentermine—SLC6A4—Serotonin Transporter Activity—TPH2—attention deficit hyperactivity disorder	0.00292	0.0303	CbGpPWpGaD
Phentermine—MAOB—Alpha-synuclein signaling—STUB1—attention deficit hyperactivity disorder	0.00281	0.0291	CbGpPWpGaD
Phentermine—MAOA—Serotonin Transporter Activity—TPH2—attention deficit hyperactivity disorder	0.00239	0.0248	CbGpPWpGaD
Phentermine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0022	0.0228	CbGpPWpGaD
Phentermine—MAOB—Dopamine metabolism—COMT—attention deficit hyperactivity disorder	0.00202	0.021	CbGpPWpGaD
Phentermine—MAOB—Dopamine metabolism—MAOA—attention deficit hyperactivity disorder	0.00201	0.0208	CbGpPWpGaD
Phentermine—MAOA—Serotonin Transporter Activity—SLC6A4—attention deficit hyperactivity disorder	0.00191	0.0198	CbGpPWpGaD
Phentermine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.00187	0.0194	CbGpPWpGaD
Phentermine—SLC6A4—Serotonin Transporter Activity—MAOA—attention deficit hyperactivity disorder	0.00176	0.0182	CbGpPWpGaD
Phentermine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.00174	0.018	CbGpPWpGaD
Phentermine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.00173	0.0179	CbGpPWpGaD
Phentermine—SLC6A3—Alpha-synuclein signaling—STUB1—attention deficit hyperactivity disorder	0.00164	0.017	CbGpPWpGaD
Phentermine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.00158	0.0298	CbGeAlD
Phentermine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00145	0.0273	CbGeAlD
Phentermine—MAOB—forebrain—attention deficit hyperactivity disorder	0.00137	0.0259	CbGeAlD
Phentermine—MAOA—Norepinephrine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00129	0.0134	CbGpPWpGaD
Phentermine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00127	0.024	CbGeAlD
Phentermine—MAOA—Dopamine metabolism—COMT—attention deficit hyperactivity disorder	0.00127	0.0132	CbGpPWpGaD
Phentermine—SLC6A4—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00124	0.0129	CbGpPWpGaD
Phentermine—SLC6A4—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00122	0.0127	CbGpPWpGaD
Phentermine—MAOB—Alpha-synuclein signaling—SLC6A3—attention deficit hyperactivity disorder	0.00119	0.0123	CbGpPWpGaD
Phentermine—MAOA—forebrain—attention deficit hyperactivity disorder	0.00117	0.0221	CbGeAlD
Phentermine—MAOB—cardiovascular system—attention deficit hyperactivity disorder	0.00116	0.0219	CbGeAlD
Phentermine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.00116	0.012	CbGpPWpGaD
Phentermine—MAOA—Biogenic Amine Synthesis—COMT—attention deficit hyperactivity disorder	0.00113	0.0117	CbGpPWpGaD
Phentermine—SLC6A2—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00107	0.0111	CbGpPWpGaD
Phentermine—SLC6A2—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00105	0.0109	CbGpPWpGaD
Phentermine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.00104	0.0197	CbGeAlD
Phentermine—MAOA—cardiovascular system—attention deficit hyperactivity disorder	0.000992	0.0187	CbGeAlD
Phentermine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000955	0.018	CbGeAlD
Phentermine—SLC6A3—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.000946	0.00982	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.000931	0.00966	CbGpPWpGaD
Phentermine—MAOB—midbrain—attention deficit hyperactivity disorder	0.000908	0.0171	CbGeAlD
Phentermine—SLC6A4—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.000885	0.00919	CbGpPWpGaD
Phentermine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000856	0.0162	CbGeAlD
Phentermine—SLC6A2—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.000854	0.00886	CbGpPWpGaD
Phentermine—Tolazoline—ADRA2C—attention deficit hyperactivity disorder	0.00083	0.116	CrCbGaD
Phentermine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000825	0.0156	CbGeAlD
Phentermine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000806	0.0152	CbGeAlD
Phentermine—SLC6A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.000802	0.00832	CbGpPWpGaD
Phentermine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000785	0.0148	CbGeAlD
Phentermine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000785	0.0148	CbGeAlD
Phentermine—MAOA—midbrain—attention deficit hyperactivity disorder	0.000774	0.0146	CbGeAlD
Phentermine—SLC6A2—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.000761	0.0079	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.000757	0.00785	CbGpPWpGaD
Phentermine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000756	0.0143	CbGeAlD
Phentermine—MAOB—nervous system—attention deficit hyperactivity disorder	0.000746	0.0141	CbGeAlD
Phentermine—MAOB—central nervous system—attention deficit hyperactivity disorder	0.000718	0.0136	CbGeAlD
Phentermine—MAOB—cerebellum—attention deficit hyperactivity disorder	0.000702	0.0132	CbGeAlD
Phentermine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000697	0.0131	CbGeAlD
Phentermine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000691	0.013	CbGeAlD
Phentermine—SLC6A4—Synaptic Vesicle Pathway—SNAP25—attention deficit hyperactivity disorder	0.000684	0.0071	CbGpPWpGaD
Phentermine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000665	0.0126	CbGeAlD
Phentermine—MAOA—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.000655	0.0068	CbGpPWpGaD
Phentermine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000655	0.0124	CbGeAlD
Phentermine—MAOA—nervous system—attention deficit hyperactivity disorder	0.000637	0.012	CbGeAlD
Phentermine—MAOA—central nervous system—attention deficit hyperactivity disorder	0.000613	0.0116	CbGeAlD
Phentermine—Pargyline—MAOA—attention deficit hyperactivity disorder	0.000605	0.0845	CrCbGaD
Phentermine—SLC6A4—brain—attention deficit hyperactivity disorder	0.0006	0.0113	CbGeAlD
Phentermine—MAOA—cerebellum—attention deficit hyperactivity disorder	0.000599	0.0113	CbGeAlD
Phentermine—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.000577	0.00599	CbGpPWpGaD
Phentermine—MAOB—brain—attention deficit hyperactivity disorder	0.00057	0.0108	CbGeAlD
Phentermine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000528	0.00997	CbGeAlD
Phentermine—MAOA—brain—attention deficit hyperactivity disorder	0.000487	0.00918	CbGeAlD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000479	0.00497	CbGpPWpGaD
Phentermine—Methamphetamine—ADRA2C—attention deficit hyperactivity disorder	0.000461	0.0644	CrCbGaD
Phentermine—MAOA—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000459	0.00476	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000427	0.00443	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000409	0.00425	CbGpPWpGaD
Phentermine—Tranylcypromine—MAOA—attention deficit hyperactivity disorder	0.00039	0.0544	CrCbGaD
Phentermine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000378	0.00714	CbGeAlD
Phentermine—Phenylpropanolamine—MAOA—attention deficit hyperactivity disorder	0.000366	0.0512	CrCbGaD
Phentermine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000364	0.00687	CbGeAlD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000363	0.00376	CbGpPWpGaD
Phentermine—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000361	0.00374	CbGpPWpGaD
Phentermine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000356	0.00672	CbGeAlD
Phentermine—Tolazoline—ADRA2A—attention deficit hyperactivity disorder	0.000354	0.0495	CrCbGaD
Phentermine—MAOA—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000352	0.00365	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00035	0.00363	CbGpPWpGaD
Phentermine—Phenylpropanolamine—DRD1—attention deficit hyperactivity disorder	0.000333	0.0465	CrCbGaD
Phentermine—SLC6A3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000327	0.00339	CbGpPWpGaD
Phentermine—Phenylpropanolamine—SLC6A3—attention deficit hyperactivity disorder	0.000316	0.0441	CrCbGaD
Phentermine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000313	0.00325	CbGpPWpGaD
Phentermine—Phenylpropanolamine—ADRA2A—attention deficit hyperactivity disorder	0.00031	0.0432	CrCbGaD
Phentermine—Pseudoephedrine—MAOA—attention deficit hyperactivity disorder	0.000309	0.0432	CrCbGaD
Phentermine—Selegiline—MAOA—attention deficit hyperactivity disorder	0.000302	0.0422	CrCbGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000301	0.00312	CbGpPWpGaD
Phentermine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000289	0.00546	CbGeAlD
Phentermine—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000289	0.00299	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000287	0.00298	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000286	0.00296	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00028	0.0029	CbGpPWpGaD
Phentermine—Dextroamphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000269	0.0375	CrCbGaD
Phentermine—Pseudoephedrine—SLC6A3—attention deficit hyperactivity disorder	0.000267	0.0373	CrCbGaD
Phentermine—Phenelzine—MAOA—attention deficit hyperactivity disorder	0.000266	0.0372	CrCbGaD
Phentermine—SLC6A4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000263	0.00273	CbGpPWpGaD
Phentermine—Pseudoephedrine—ADRA2A—attention deficit hyperactivity disorder	0.000262	0.0365	CrCbGaD
Phentermine—MAOB—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000256	0.00266	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000254	0.00264	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000254	0.00263	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000247	0.00256	CbGpPWpGaD
Phentermine—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000244	0.00254	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000235	0.00244	CbGpPWpGaD
Phentermine—Methamphetamine—MAOA—attention deficit hyperactivity disorder	0.000233	0.0325	CrCbGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000229	0.00238	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000229	0.00238	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000228	0.00237	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000226	0.00235	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000225	0.00233	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000221	0.0023	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000218	0.00227	CbGpPWpGaD
Phentermine—Amphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000216	0.0302	CrCbGaD
Phentermine—SLC6A4—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000215	0.00223	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00021	0.00218	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000208	0.00216	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000203	0.00211	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000202	0.0021	CbGpPWpGaD
Phentermine—Methamphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000201	0.028	CrCbGaD
Phentermine—SLC6A4—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.0002	0.00208	CbGpPWpGaD
Phentermine—Pseudoephedrine—SLC6A4—attention deficit hyperactivity disorder	0.0002	0.0279	CrCbGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000198	0.00206	CbGpPWpGaD
Phentermine—Methamphetamine—ADRA2A—attention deficit hyperactivity disorder	0.000197	0.0275	CrCbGaD
Phentermine—MAOA—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000188	0.00195	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000188	0.00195	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000184	0.00191	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00018	0.00187	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000176	0.00182	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000175	0.00181	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000172	0.00178	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000167	0.00174	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000167	0.00174	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000166	0.00173	CbGpPWpGaD
Phentermine—Amphetamine—SLC6A4—attention deficit hyperactivity disorder	0.000162	0.0226	CrCbGaD
Phentermine—Amphetamine—DRD2—attention deficit hyperactivity disorder	0.000161	0.0225	CrCbGaD
Phentermine—MAOA—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000161	0.00167	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000155	0.00161	CbGpPWpGaD
Phentermine—Methamphetamine—SLC6A4—attention deficit hyperactivity disorder	0.00015	0.021	CrCbGaD
Phentermine—MAOA—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000144	0.00149	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000144	0.00149	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000142	0.00148	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000142	0.00148	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000141	0.00146	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000134	0.00139	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000132	0.00137	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000131	0.00136	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000131	0.00136	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00013	0.00135	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000128	0.00133	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000111	0.00115	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000109	0.00113	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000105	0.00109	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000101	0.00105	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000101	0.00105	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000101	0.00104	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	9.09e-05	0.000943	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	7.45e-05	0.000773	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	7.42e-05	0.00077	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	7.3e-05	0.000757	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	7.3e-05	0.000757	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.24e-05	0.000751	CbGpPWpGaD
Phentermine—MAOB—Metabolism—TPH2—attention deficit hyperactivity disorder	7.23e-05	0.00075	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.23e-05	0.00075	CbGpPWpGaD
Phentermine—MAOB—Metabolism—DPYD—attention deficit hyperactivity disorder	7.11e-05	0.000738	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	7e-05	0.000726	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.95e-05	0.000721	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.93e-05	0.00072	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.9e-05	0.000716	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.89e-05	0.000715	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.84e-05	0.00071	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.61e-05	0.000686	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.57e-05	0.000682	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.93e-05	0.000615	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.88e-05	0.000611	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.84e-05	0.000607	CbGpPWpGaD
Phentermine—MAOB—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.78e-05	0.0006	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.5e-05	0.000571	CbGpPWpGaD
Phentermine—MAOA—Metabolism—TPH2—attention deficit hyperactivity disorder	4.54e-05	0.000471	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.54e-05	0.000471	CbGpPWpGaD
Phentermine—MAOA—Metabolism—DPYD—attention deficit hyperactivity disorder	4.46e-05	0.000463	CbGpPWpGaD
Phentermine—MAOB—Metabolism—COMT—attention deficit hyperactivity disorder	4.38e-05	0.000454	CbGpPWpGaD
Phentermine—MAOB—Metabolism—MAOA—attention deficit hyperactivity disorder	4.35e-05	0.000451	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.15e-05	0.00043	CbGpPWpGaD
Phentermine—MAOA—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.63e-05	0.000376	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.45e-05	0.000358	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.86e-05	0.000297	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.84e-05	0.000294	CbGpPWpGaD
Phentermine—MAOA—Metabolism—COMT—attention deficit hyperactivity disorder	2.75e-05	0.000285	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.42e-05	0.000251	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.97e-05	0.000205	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.97e-05	0.000205	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	1.96e-05	0.000203	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.96e-05	0.000203	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.94e-05	0.000202	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.93e-05	0.0002	CbGpPWpGaD
Phentermine—MAOB—Metabolism—EP300—attention deficit hyperactivity disorder	1.88e-05	0.000195	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.81e-05	0.000187	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.79e-05	0.000186	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.67e-05	0.000174	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.67e-05	0.000174	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.65e-05	0.000171	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.58e-05	0.000164	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.56e-05	0.000162	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.53e-05	0.000159	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.5e-05	0.000156	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.49e-05	0.000155	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.34e-05	0.000139	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.27e-05	0.000132	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.2e-05	0.000124	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.19e-05	0.000123	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.19e-05	0.000123	CbGpPWpGaD
Phentermine—MAOA—Metabolism—EP300—attention deficit hyperactivity disorder	1.18e-05	0.000122	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.18e-05	0.000122	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.14e-05	0.000119	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	1.01e-05	0.000105	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.01e-05	0.000104	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.76e-06	0.000101	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.13e-06	5.32e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	5.09e-06	5.28e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.35e-06	4.51e-05	CbGpPWpGaD
